Home / Publications / Navigating clinical trial disclosures: No reasonable...

Navigating clinical trial disclosures: No reasonable expectation of success in a patient sub-population in view of prior art reporting phase III clinical trial (T 1437/21)

11/04/2024

Recent EPO Board of Appeal decision T 1437/21 adds to a growing number of decisions concerning the patentability of second or further medical use inventions where the prior art relates to a clinical trial. At a time when the European Medicines Agency (EMA) is...

Read more

Authors

Portrait ofNadège Beynon
Nadège Beynon
Associate
London
Sophie Skidmore
Trainee
London